Ghrelin Resistance in Adolescents With Idiopathic Scoliosis
Primary Purpose
Scoliosis
Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Osteoblast sample
Sponsored by
About this trial
This is an interventional basic science trial for Scoliosis focused on measuring Adolescent idiopathic Scoliosis, Ghrelin
Eligibility Criteria
Inclusion Criteria:
Group 1 :
- AIS : spine deformity with angle above 10°,without detected cause
- Informed consent obtained
Group 2 :
- Secondary scoliosis due to chronic illness, neurologic or syndromic, eligible for spine surgery
- Spine surgery for reason other than scoliosis
- Informed consent obtained
Exclusion Criteria:
- Not primary scoliosis
- No consent
- Legal obstacle
Sites / Locations
- University Hospital of Toulouse
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Experimental
Arm Label
patients with AIS
control patients
Arm Description
Patients will have 'Osteoblast sample'
Outcomes
Primary Outcome Measures
Testing ghrelin cellular resistance by intracellular cAMP dosage
Testing ghrelin cellular resistance in AIS by measuring the variation of the intracellular cAMP level in response to ghrelin in osteoblast cells in vitro of AIS patients versus controls
Secondary Outcome Measures
ghrelin level in serum
Measure the ghrelin level in the serum of AIS patients versus controls
ghrelin levels in cellular supernatants
Measure the ghrelin levels in cellular supernatants of osteoblasts from AIS and controls patients in order to evaluate the ghrelin production of the cells.
Full Information
NCT ID
NCT02829476
First Posted
July 4, 2016
Last Updated
May 10, 2017
Sponsor
University Hospital, Toulouse
1. Study Identification
Unique Protocol Identification Number
NCT02829476
Brief Title
Ghrelin Resistance in Adolescents With Idiopathic Scoliosis
Official Title
Ghrelin Cellular Resistance Study in Adolescents With Idiopathic Scoliosis
Study Type
Interventional
2. Study Status
Record Verification Date
May 2017
Overall Recruitment Status
Completed
Study Start Date
March 2010 (undefined)
Primary Completion Date
July 2012 (Actual)
Study Completion Date
July 2012 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Toulouse
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Adolescent idiopathic Scoliosis (AIS) is the most common spine pathology. It is opposed to secondary scoliosis due to chronic diseases. Many hypotheses have been made to elucidate the origin of this illness. Recently, the melatonin pathway has been investigated as pinealectomy of the chicken creates a scoliosis that resembles AIS and melatonin supplementation reverses the process. In addition administration of melatonin to AIS patients improved the pathology. However this hypothesis has shown controversial results. Recent studies have demonstrated melatonin cellular resistance in osteoblastic cells from AIS patients. Melatonin acts through G protein coupled receptor (GPCR), mainly using the Gi pathway. In AIS osteoblasts, this pathway is blocked leading to a decrease in the inactivation of the adenylyl cyclase and therefore maintenance of high level of cyclic adenosine monophosphate (cAMP) concentrations in the cells. As modulation of cAMP is important for osteogenesis such resistance may be critical for the initiation or the development of AIS.
Gi signalization is used by several other GPCR, thus, this hormonal resistance could logically be found in other hormonal or mediator pathways. A precedent study previously focused on ghrelin in AIS, and demonstrated that AIS patients possess elevated plasmatic values of ghrelin. This study also observed decreased response to ghrelin in AIS cultures osteoblasts.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Scoliosis
Keywords
Adolescent idiopathic Scoliosis, Ghrelin
7. Study Design
Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
45 (Actual)
8. Arms, Groups, and Interventions
Arm Title
patients with AIS
Arm Type
Experimental
Arm Description
Patients will have 'Osteoblast sample'
Arm Title
control patients
Arm Type
Experimental
Intervention Type
Biological
Intervention Name(s)
Osteoblast sample
Intervention Description
culture osteoblasts obtained from vertebrae fragments from 30 patients with AIS and from 10 control patients with secondary scoliosis
Primary Outcome Measure Information:
Title
Testing ghrelin cellular resistance by intracellular cAMP dosage
Description
Testing ghrelin cellular resistance in AIS by measuring the variation of the intracellular cAMP level in response to ghrelin in osteoblast cells in vitro of AIS patients versus controls
Time Frame
baseline
Secondary Outcome Measure Information:
Title
ghrelin level in serum
Description
Measure the ghrelin level in the serum of AIS patients versus controls
Time Frame
baseline
Title
ghrelin levels in cellular supernatants
Description
Measure the ghrelin levels in cellular supernatants of osteoblasts from AIS and controls patients in order to evaluate the ghrelin production of the cells.
Time Frame
baseline
10. Eligibility
Sex
All
Minimum Age & Unit of Time
12 Years
Maximum Age & Unit of Time
15 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Group 1 :
AIS : spine deformity with angle above 10°,without detected cause
Informed consent obtained
Group 2 :
Secondary scoliosis due to chronic illness, neurologic or syndromic, eligible for spine surgery
Spine surgery for reason other than scoliosis
Informed consent obtained
Exclusion Criteria:
Not primary scoliosis
No consent
Legal obstacle
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
SALLES Jean-Pierre, MD
Organizational Affiliation
University Hospital, Toulouse
Official's Role
Principal Investigator
Facility Information:
Facility Name
University Hospital of Toulouse
City
Toulouse
ZIP/Postal Code
31000
Country
France
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
26628906
Citation
Sales de Gauzy J, Gennero I, Delrous O, Salles JP, Lepage B, Accadbled F. Fasting total ghrelin levels are increased in patients with adolescent idiopathic scoliosis. Scoliosis. 2015 Nov 30;10:33. doi: 10.1186/s13013-015-0054-7. eCollection 2015.
Results Reference
result
Learn more about this trial
Ghrelin Resistance in Adolescents With Idiopathic Scoliosis
We'll reach out to this number within 24 hrs